2. Epigenetics Protein Tyrosine Kinase/RTK JAK/STAT Signaling Stem Cell/Wnt Immunology/Inflammation
  3. JAK Interleukin Related STAT
  4. JAK1-IN-20

JAK1-IN-20 (Compound 38) 是一种肠道限制性、口服活性的、选择性的 JAK1 抑制剂，IC50 为 <0.5 nM。JAK1-IN-20 可抑制 JAK1 的酶活性，并减少促炎细胞因子 (TNF-α、IL-6) 的产生、抑制 STAT3 的磷酸化。JAK1-IN-20 可改善溃疡性结肠炎。JAK1-IN-20 可用于炎症性肠病的研究。

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

JAK1-IN-20

JAK1-IN-20 Chemical Structure

CAS No. : 3106963-85-0

1.  客户无需承担相应的运输费用。

2.  同一机构（单位）同一产品试用装仅限申领一次，同一机构（单位）一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户。

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

JAK1-IN-20 相关抗体

Top Publications Citing Use of Products

查看 JAK 亚型特异性产品:

查看所有亚型
JAK1 JAK2 JAK3 Tyk2 JAK

查看 Interleukin Related 亚型特异性产品:

查看所有亚型
IL-1 IL-2 IL-3 IL-4 IL-5 IL-6 IL-8 IL-10 IL-12 IL-13 IL-15 IL-17 IL-23 IL-7 IL-33 IL-22 IL-18

查看 STAT 亚型特异性产品:

查看所有亚型
STAT3 STAT5 STAT6 STAT1

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

JAK1-IN-20 (Compound 38) is a gut-restricted, orally active, selective JAK1 inhibitor with an IC50 of <0.5 nM. JAK1-IN-20 inhibits the enzymatic activity of JAK1, reduces the production of proinflammatory cytokines (TNF-α, IL-6), and suppresses the phosphorylation of STAT3. JAK1-IN-20 ameliorates ulcerative colitis. JAK1-IN-20 can be used for the research of inflammatory bowel disease[1].

IC50 & Target[1]

JAK1

<0.5 nM (IC50)

IL-6

 

STAT3

 

体外研究
(In Vitro)

JAK1-IN-20 可强效且选择性地抑制 JAK1 酶活性，其 IC50 < 0.5 nM，对 JAK2、JAK3 和 TYK2 的选择性分别超过 312 倍、20000 倍和 354 倍[1]。
JAK1-IN-20 (30 min) 可强效抑制 HEK-Blue IL-6 细胞中 IL-6 诱导的 JAK/STAT3 信号通路，其 IC50 为 28.0 nM[1]。

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

JAK1-IN-20 相关抗体:

Western Blot Analysis[1]

Cell Line: TF-1 cells, H9 cells
Concentration: Dose-response range; 100 nM, 500 nM (TF-1 cells, STAT3); 1000 nM (H9 cells, STAT1); 2000 nM (TF-1 cells, STAT5); 1000 nM tofacitinib (control)
Incubation Time: 1 h
Result: Potently suppressed IL-6-induced STAT3 phosphorylation with an IC50 of 218.6 nM.
Showed a concentration-dependent inhibitory profile and achieved comparable efficacy to 1000 nM tofacitinib at 100 nM.
Reduced IL-6-induced STAT3 phosphorylation at 500 nM.
Reduced IFN-α-induced STAT1 phosphorylation at 1000 nM.
Reduced GM-CSF-induced STAT5 phosphorylation at 2000 nM.
药代动力学
(Parmacokinetics)
Species Dose Route Plasma Concentration T1/2 AUC0-24 Vd CL Cmax Bioavailability
Rat[1] 1 mg/kg i.v. / 0.65 h 610 ng·h/mL 1.08 L/kg 27.5 mL/min/kg / /
Rat[1] 5 mg/kg p.o. / 1.3 h 254 ng·h/mL / / 167 ng/mL 8.3 %
Mice[1] 30 mg/kg p.o. <1 (0.5 h) ng/mL / / / / / /
体内研究
(In Vivo)

JAK1-IN-20 (10-30 mg/kg；灌胃；每日一次) 可显著改善 DSS 诱导的雌性 C57BL/6J 小鼠急性溃疡性结肠炎，降低疾病活动度、增加结肠长度、抑制促炎细胞因子的产生并改善结肠组织病理学表现[1]。

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: C57BL/6J (female, 7-8 weeks old, DSS-induced ulcerative colitis)[1]
Dosage: 10 mg/kg; 30 mg/kg
Administration: p.o.; daily
Result: Significantly reduced DAI scores compared to vehicle controls at 30 mg/kg.
Increased colon length and reduced colon wet weight relative to vehicle controls at 30 mg/kg.
Suppressed colon tissue TNF-α and IL-6 levels compared to vehicle controls at 30 mg/kg.
Reduced colonic tissue damage, including mucosal erosion, crypt architecture loss, and inflammatory cell infiltration, relative to vehicle controls at 30 mg/kg.
Demonstrated a dose-dependent improvement in disease outcomes.
分子量

537.97

Formula

C26H25ClFN7O3
CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
纯度 & 产品资料
参考文献

JAK1-IN-20 相关分类

  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

JAK1-IN-203106963-85-0JAKInterleukin RelatedSTATJanus kinaseILJAK2Caco-2TF-1 cellsinflammatory bowel diseaseJAK3STAT3TYK2HEK-Blue IL-6 cellsC57BL/6J miceJAK1Inhibitorinhibitorinhibit

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称：

  

* 需求量：

* 客户姓名：

 

* Email：

* 电话：

 

* 公司或机构名称：

   留言给我们：

Bulk Inquiry

Inquiry Information

产品名称：
JAK1-IN-20
目录号：
HY-181872
需求量：

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

   产品名称：

  

* Lot #：

* 客户姓名：

 

* Email：

   电话：

 

* 部门：

* 公司或机构名称：

 

   留言给我们：

Request for HNMR Report

We have received your request and will respond to you as soon as possible.

嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z